Abstract
The benefits of using lactic acid bacteria in the food chain, both through direct consumption and production of ingredients, are increasingly recognised by the food industry and consumers alike. The regulatory environment surrounding these products is diverse, covering foods and food ingredients, processing aids, feed additives and dietary supplements. On a global basis, there are different approaches taken by the various regulatory authorities. While in Europe, the national legislation is gradually being harmonised, predominantly through the Novel Foods Regulation, there is still a wide disparity between the stringency of regulation of microbial products fed to animals and the comparatively relaxed approach to `non-novel’ microbial products intended for human consumption. In the United States, the onus is on self-regulation of the manufacturer, with the Generally Recognised As Safe (GRAS) and Dietary Supplement Health Education Act (DSHEA) notification schemes encouraging industry to be more open about the ingredients they market. In Japan, the Foods for Special Health Use system continues to gain recognition as more products are approved, and is a potential model for other countries in regulating functional foods. Despite the different approaches to regulating these products, safety of microorganisms such as lactic acid bacteria in the food chain is paramount in all countries. This paper discusses the regulatory requirements of microbial products, predominantly lactic acid bacteria within the global markets, focusing mainly on the developments in Europe.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amended proposal for a Directive of the European Parliament and of the Council on the approximation of the laws of the member states relating to food supplements/* COM/2001/0159 final — COD 2000/0080* /.
April 17 1997, Substances Generally Recognized as Safe; Proposed Rule. U.S. Food and Drug Administration.
Association of American Feed Control Officials, Official Publication 2002.
Commission Directive 94/40/EC of 23 July 1994 amending Council directive 87/153/EEC fixing guidelines for the assessment of additives in animal nutrition.
Commission Recommendation of 29 July 1997 concerning the scientific aspects and the presentation of information necessary to support applications for the placing on the market of novel foods and novel food ingredients and the preparation of initial assessment reports under Regulation (EC) No 258/97 of the European Parliament and of the Council (97/618/EC).
Commission Regulation (EC) No 2200/2001 of 17 October 2001 concerning provisional authorisations of additives in feeding-stuffs.
Council Directive 70/524/EEC of 23 November 1970 concerning additives in feedingstuffs.
Council Directive 87/153/EEC of 16 February 1987 fixing guidelines for the assessment of additives in animal nutrition.
Council Directive 90/220/EEC of 23 April 1990 on the deliberate release into the environment of genetically modified organisms.
Council Directive 93/113/EC of 14 December 1993 concerning the use and marketing of enzymes, micro-organisms and their preparations in animal nutrition.
Dietary Supplement Health and Education Act of 1994. U.S. Food and Drug Administration.
Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC.
Discussion Paper on nutrition claims and functional claims (SANCO 1341/2001), prepared by Directorate General Health and Consumer Protection.
Joint Health Claims Initiative, Code of Practice on Health Claims on Food, UK.
List of Enzymes, Microorganisms and their preparations in animal nutrition permitted for use in individual member states (96/C 263/03).
Nutrition Labelling and Education Act (NLEA) of 1990, U.S. Food and Drug Administration.
Opinion of the Scientific Committee on Animal Nutrition on the criteria for assessing the safety of mircoorganisms resistant to antibiotics of human clinical and veterinary importance (adopted 3 July 2001).
Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients.
Salminen S and von Wright A (1998) Current probiotics — safety assured? Microbial Ecol. Health Dis. 10: 68–77.
Strategy for Implementation of Pearson Court Decision December 1 1999, Food Labeling: Health Claims and Label Statements for Dietary Supplements.
The Food and Drug Administration Modernization Act (FDAMA) of 1997. U.S. Food and Drug Administration.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Feord, J. (2002). Lactic acid bacteria in a changing legislative environment. In: Siezen, R.J., Kok, J., Abee, T., Schasfsma, G. (eds) Lactic Acid Bacteria: Genetics, Metabolism and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-2029-8_24
Download citation
DOI: https://doi.org/10.1007/978-94-017-2029-8_24
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-6141-6
Online ISBN: 978-94-017-2029-8
eBook Packages: Springer Book Archive